Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Moodys
Cantor Fitzgerald
Chinese Patent Office
McKinsey
Queensland Health
Farmers Insurance
Harvard Business School
Daiichi Sankyo
US Army

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,282,913

« Back to Dashboard

Summary for Patent: 8,282,913
Title:Ion binding polymers and uses thereof
Abstract: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hyperkalemia, such as hyperkalemia caused by renal failure and/or the use of hyperkalemia causing drugs.
Inventor(s): Charmot; Dominique (Campbell, CA), Chang; Han-Ting (Livermore, CA), Liu; Mingjun (Campbell, CA), Klaerner; Gerrit (San Jose, CA)
Assignee: Relypsa, Inc. (Santa Clara, CA)
Application Number:12/055,746
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 8,282,913

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Relypsa Inc VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-001 Oct 21, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Relypsa Inc VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-002 Oct 21, 2015 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Relypsa Inc VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739-003 Oct 21, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,282,913

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,778,324 Ion binding polymers and uses thereof ➤ Sign Up
7,429,394 Ion binding compositions ➤ Sign Up
7,776,319 Methods and compositions for treatment of ion imbalances ➤ Sign Up
8,282,960 Ion binding compositions ➤ Sign Up
8,475,780 Ion binding polymers and uses thereof ➤ Sign Up
7,854,924 Methods and compositions for treatment of ion imbalances ➤ Sign Up
8,192,758 Ion binding compositions ➤ Sign Up
8,287,847 Ion binding polymers and uses thereof ➤ Sign Up
8,216,560 Ion binding polymers and uses thereof ➤ Sign Up
8,147,873 Methods and compositions for treatment of ion imbalances ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,282,913

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 453383 ➤ Sign Up
Austria 460927 ➤ Sign Up
Australia 2005228696 ➤ Sign Up
Australia 2005231383 ➤ Sign Up
Australia 2005231424 ➤ Sign Up
Australia 2010214729 ➤ Sign Up
Australia 2010214732 ➤ Sign Up
Australia 2012254879 ➤ Sign Up
Australia 2016216697 ➤ Sign Up
Brazil PI0509331 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
Chinese Patent Office
Harvard Business School
US Department of Justice
Deloitte
Cerilliant
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot